Hello and Welcome to Patientsville.com, Your Source for all ETODOLAC information. We are dedicated to provide You with ETODOLAC safety information. Learn about ETODOLAC serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETODOLAC Safety Reports
Total ETODOLAC reports: 75.ETODOLAC FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 57.
Take ETODOLAC Side Effects Survey or Share Your ETODOLAC Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on Jan 03, 2007. Male patient, 56 years of age, weighting 190.0 lb, was diagnosed with arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal distension, dyspepsia, flatulence, lip swelling, oedema peripheral, pruritus, urticaria. ETODOLAC dosage: 800MG 1/DAY PO. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2006. Male patient, 33 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dyspnoea, erythema. ETODOLAC dosage: 400 MG 1X PER 1 DAY. During the same period patient was treated with RINLAXER, ISALON, AZULENE, MOHRUS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on Dec 28, 2006. Female patient, 79 years of age, was diagnosed with lumbar vertebral fracture and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: colitis collagenous, colon cancer, diarrhoea. ETODOLAC dosage: unknown. During the same period patient was treated with OTSUJITOU, SENNA LIQUID. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Physician from JAPAN on Jan 11, 2007. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, gastric ulcer perforation, gastrointestinal fistula, pleural effusion, pleural fistula, pneumothorax. ETODOLAC dosage: 400 MG, QD,. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Feb 15, 2007. Male patient, 81 years of age, was diagnosed with pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: anaemia, gastric ulcer. ETODOLAC dosage: unknown. During the same period patient was treated with FERROUS SUL, FINASTERIDE, OMEPRAZOLE, TERAZOSIN, ZOLOFT. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Physician from JAPAN on Feb 06, 2007. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: back pain, chest pain, cold sweat, dyspnoea, gastric ulcer perforation, gastrointestinal fistula, pallor, pleural effusion, pneumothorax. ETODOLAC dosage: 400 MG, QD;. During the same period patient was treated with PREDNISOLONE, METHOTREXATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Feb 28, 2007. Male patient, 63 years of age, weighting 222.7 lb, was diagnosed with pain, depression and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: gastrointestinal erosion, gastrointestinal ulcer, haematocrit decreased, haemoglobin decreased, rectal haemorrhage. ETODOLAC dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2007. Female patient, 47 years of age, weighting 130.0 lb, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, liver transplant, pain, stomach discomfort. ETODOLAC dosage: 800 MG TWICE DAILY PO. During the same period patient was treated with TRAMADAL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported ETODOLAC problem on Nov 20, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, chest discomfort, chest pain, dyspnoea, gastric ulcer perforation, gastrointestinal fistula, inflammation, pleural effusion, pneumothorax. ETODOLAC dosage: 400 MG; QD. During the same period patient was treated with PREDNISOLONE, ORAPRED, METHOTREXATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Health Professional from UNITED KINGDOM on Feb 20, 2007. Female patient, 62 years of age, weighting 176.4 lb, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: anaemia, faeces discoloured, gastrointestinal haemorrhage. ETODOLAC dosage: 600 MG, QD, ORAL. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Feb 26, 2007. Male patient, 54 years of age, was diagnosed with back pain, hypertension and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, hypotension, hypovolaemia, nausea, renal failure acute, tachycardia. ETODOLAC dosage: 400 MG, BID, ORAL. During the same period patient was treated with PRINIVIL. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Female patient, 60 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: chills, rash macular, swelling face. ETODOLAC dosage: unknown. During the same period patient was treated with AMOXICILLIN, REBIF. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Apr 11, 2007. Male patient was diagnosed with skeletal injury and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: haematemesis, ill-defined disorder, oesophagitis. ETODOLAC dosage: 400 MG BID PO. During the same period patient was treated with FINASTERIDE, FLEXERIL, LISINOPRIL, LASIX, METOPROLOL SUCCINATE. Patient recovered.
ETODOLAC problem was reported by a Pharmacist from UNITED STATES on Apr 17, 2007. Male patient was diagnosed with arthritis, pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: asthenia, gastrointestinal haemorrhage. ETODOLAC dosage: 400MG BID PO. During the same period patient was treated with IBUPROFEN, METOPROLOL SUCCINATE, VARDENAFIL, LISINOPRIL. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported ETODOLAC problem on Apr 19, 2007. Male patient, weighting 227.0 lb, was diagnosed with psoriatic arthropathy and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, duodenal ulcer, haemoglobin decreased, rectal haemorrhage, syncope. ETODOLAC dosage: 500 MG BID PO. During the same period patient was treated with METHOTREXATE, SULFASALAZINE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 60 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: chills, erythema, jaw disorder, multiple sclerosis relapse, muscular weakness, rash macular, swelling face. ETODOLAC dosage: unknown. During the same period patient was treated with AMOXICILLIN, REBIF. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from TURKEY reported ETODOLAC problem on Apr 11, 2007. Female patient, 52 years of age, was diagnosed with osteoarthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: burning sensation, dermatitis, pruritus, skin depigmentation. ETODOLAC dosage: unknown. During the same period patient was treated with NAXOPREN, FLURBIPROFEN, DICLOFENAC, PIROXICAM. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Male patient, 55 years of age, weighting 175.0 lb, was diagnosed with inflammation, post procedural complication and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: dysphagia, glossitis, swollen tongue. ETODOLAC dosage: unknown. During the same period patient was treated with HYDROCODINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on May 07, 2007. Male patient, 76 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: melaena. ETODOLAC dosage: unknown. Patient recovered.
ETODOLAC problem was reported by a Pharmacist from UNITED STATES on May 17, 2007. Male patient, 55 years of age, weighting 223.0 lb, was diagnosed with inflammation, intervertebral disc protrusion, pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: burning sensation, gastrointestinal disorder, rectal haemorrhage. ETODOLAC dosage: 300 MG TID PO. During the same period patient was treated with SKELAXIN. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on May 21, 2007. Male patient, 55 years of age, weighting 223.0 lb, was diagnosed with inflammation, intervertebral disc protrusion, pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: burning sensation, gastrointestinal disorder, rectal haemorrhage. ETODOLAC dosage: 300 MG TID PO. During the same period patient was treated with SKELAXIN. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, 57 years of age, weighting 200.0 lb, was diagnosed with arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, rash erythematous, rash pruritic, swelling face. ETODOLAC dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on June 25, 2007. Male patient, weighting 183.0 lb, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: erosive oesophagitis, gastrointestinal haemorrhage, ulcer. ETODOLAC dosage: 200MG BID PRN PO. During the same period patient was treated with CLOPIDOGREL, METHOTREXATE, VICODIN. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, 71 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal haemorrhage, incorrect dose administered. ETODOLAC dosage: 500MG BID PO. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported ETODOLAC problem on July 05, 2006. Female patient, 48 years of age, weighting 177.7 lb, was diagnosed with patellofemoral pain syndrome and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: erythema, photodermatosis, rash papular, skin exfoliation, urticaria. ETODOLAC dosage: 400 MG THREE TIMES DAILY PO. Patient recovered.
ETODOLAC problem was reported by a Health Professional from JAPAN on June 27, 2006. Male patient, 78 years of age, was diagnosed with pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. ETODOLAC dosage: 400 MG 1X PER 1 DAY ORAL. During the same period patient was treated with FAMOTIDINE, AMLODIPINE BESYLATE, ASPIRIN, MAGNESIUM OXIDE, TAMSULOSIN HYDROCHLORIDE, ETIZOLAM, PANTETHINE. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on July 13, 2006. Male patient, 56 years of age, weighting 194.7 lb, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. ETODOLAC dosage: unknown. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2006. Male patient, 61 years of age, was diagnosed with rotator cuff syndrome and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chest pain, dyspepsia, hyperhidrosis, oesophageal spasm. ETODOLAC dosage: 400 MG; BID; PO. During the same period patient was treated with LIPITOR, VALSARTAN, NEXIUM, SAW PALMETTO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on July 10, 2006. Male patient, 78 years of age, was diagnosed with pain, insomnia and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, cardiac arrest, inflammation, interstitial lung disease, productive cough, respiratory arrest, restlessness, stridor, vomiting. ETODOLAC dosage: 400 MG 1X PER 1 DAY ORAL. During the same period patient was treated with ETIZOLAM, FAMOTIDINE, AMLODIPINE BESYLATE, ASPIRIN, MAGNESIUM OXIDE, TAMSULOSIN HYDROCHLORIDE, PANTETHINE. Patient was hospitalized. Patient died.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 28, 2006. Male patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: fatigue, haemoglobin decreased, malaise, rectal haemorrhage. ETODOLAC dosage: 600 MG, ORAL. During the same period patient was treated with LEFLUNOMIDE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on July 19, 2006. Female patient, 63 years of age, weighting 217.2 lb, was diagnosed with arthralgia, back pain, osteoarthritis, lip and/or oral cavity cancer, oral candidiasis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: renal failure acute. ETODOLAC dosage: 400MG BID PO SEVERAL YEARS. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient, 63 years of age, was diagnosed with pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: gastric ulcer, gastrointestinal haemorrhage. ETODOLAC dosage: 300 MG BID. During the same period patient was treated with PLAVIX, ZOCOR, METFORMIN, TRAZODONE, CLONAZEPAM, VENLAFAXINE, LISINOPRIL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on July 19, 2006. Male patient, 68 years of age, was diagnosed with pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: renal failure acute. ETODOLAC dosage: 300-600 MG BID PRN. During the same period patient was treated with GABAPENTIN, ASPIRIN, ATENOLOL, BACLOFEN, CITALOPRAM HYDROBROMIDE, VARDENAFIL, TRAZODONE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on July 18, 2006. Male patient, 46 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, blood lactate dehydrogenase increased, blood urine present, dyspepsia, face oedema, renal failure acute. ETODOLAC dosage: 300 MG 1X PER 1 DAY ORAL. During the same period patient was treated with AURANOFIN, BUCILLAMINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on July 19, 2006. Female patient, 91 years of age, was diagnosed with pain, abdominal pain upper, insomnia, lumbar spinal stenosis, hepatic function abnormal, supraventricular tachycardia and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer perforation. ETODOLAC dosage: 400 MG 1X PER 1 DAY ORAL. During the same period patient was treated with ALDIOXA, ALPRAZOLAM, LIMAPROST, SERRAPEPTASE, TIZANIDINE, URSODIOL, VERAPAMIL, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Health Professional from JAPAN on Aug 03, 2006. Female patient, 81 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia chronic. ETODOLAC dosage: 400 MG 1X PER 1 DAY. During the same period patient was treated with GASMOTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on Aug 01, 2006. Female patient, 28 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: hepatic failure, jaundice, nausea, portal vein thrombosis, vomiting. ETODOLAC dosage: 400MG, BID, ORAL. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Health Professional from UNITED STATES on Aug 25, 2006. Female patient, 34 years of age, weighting 200.0 lb, was diagnosed with stevens-johnson syndrome and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: dyspnoea, loss of consciousness, pruritus, stevens-johnson syndrome. ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Aug 28, 2006. Male patient, 72 years of age, weighting 223.1 lb, was diagnosed with musculoskeletal pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: duodenitis, gastritis erosive, gastrointestinal haemorrhage, osteoarthritis, radiation injury. ETODOLAC dosage: 300MG BID PO. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Aug 21, 2006. Female patient, 81 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia chronic. ETODOLAC dosage: 400 MG, 1X PER 1 DAY; ORAL. During the same period patient was treated with MAGNESIUM OXIDE, GASMOTIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported ETODOLAC problem on Oct 25, 2005. Female patient, 82 years of age, was diagnosed with pain in extremity and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, palpitations. ETODOLAC dosage: 600 MILLIGRAM QD ORAL. During the same period patient was treated with SYNTHROID, ZOLOFT, HYZAAR, MEDROL. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 46 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, blood lactate dehydrogenase increased, blood urine present, dyspepsia, face oedema, renal failure acute. ETODOLAC dosage: 300 MG 1X PER 1 DAY ORAL. During the same period patient was treated with AURANOFIN, BUCILLAMINE. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported ETODOLAC problem on Sept 01, 2006. Female patient, 83 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, white blood cell count increased. ETODOLAC dosage: unknown. During the same period patient was treated with RISEDRONATE, CALCITONIN SALMON. Patient recovered.
ETODOLAC problem was reported by a Health Professional from UNITED KINGDOM on Aug 29, 2006. Female patient, 52 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, cerebrovascular accident. ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on Aug 01, 2006. Female patient, 28 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: bile duct stone, hepatic failure, hepatitis acute, portal vein thrombosis. ETODOLAC dosage: 400MG, BID; ORAL. During the same period patient was treated with NORFLEX, LORTAB. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Sept 13, 2006. Female patient, 83 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased, liver function test abnormal, lymphocyte morphology abnormal, lymphocyte stimulation test positive, white blood cell count increased. ETODOLAC dosage: unknown. During the same period patient was treated with RISEDRONATE, CALCITONIN SALMON. Patient recovered.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on Sept 20, 2006. Female patient, 83 years of age, was diagnosed with hip arthroplasty and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia acute, lymphocyte stimulation test positive, respiratory distress. ETODOLAC dosage: 400 MG 1X PER 1 DAY ORAL. During the same period patient was treated with CARVEDILOL, REBAMIPIDE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Physician from JAPAN on Sept 20, 2006. Male patient, 61 years of age, was diagnosed with arthralgia and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: colon cancer. ETODOLAC dosage: 200 MG, BID, ORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on Aug 01, 2006. Female patient, 28 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: bile duct stone, hepatic failure, hepatitis acute, malaise, portal vein thrombosis. ETODOLAC dosage: 400MG, BID, ORAL. During the same period patient was treated with NORFLEX, LORTAB. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Female patient was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: pruritus. ETODOLAC dosage: 400 MG 1X PER 1 DAY ORAL. Patient recovered.
Physician from UNITED STATES reported ETODOLAC problem on Oct 25, 2005. Female patient, 82 years of age, was diagnosed with pain in extremity and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, palpitations. ETODOLAC dosage: 600 MILLIGRAM QD ORAL. During the same period patient was treated with SYNTHROID, ZOLOFT, HYZAAR, MEDROL. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Pharmacist from UNITED STATES on Oct 10, 2006. Male patient, 59 years of age, was diagnosed with pain, prophylaxis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, gastrointestinal haemorrhage. ETODOLAC dosage: 300 MG TID. During the same period patient was treated with ASPIRIN, NAPROXEN, BUPROPION, NITROGLYCERIN, TRAMADOL, ATORVASTATIN CALCIUM, CLOPIDOGREL, FOSINOPRIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on Oct 12, 2006. Male patient, 65 years of age, weighting 126.1 lb, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. ETODOLAC dosage: 800 MG, 400 MG BID ORAL. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Sept 27, 2006. Female patient, 72 years of age, was diagnosed with neck pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: epidermal necrosis. ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Oct 24, 2006. Male patient was diagnosed with osteoarthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: rectal haemorrhage. ETODOLAC dosage: 400 MG BID PO. During the same period patient was treated with VITAMINS WITH MINERALS, ASPIRIN, CITALOPRAM HYDROBROMIDE, FINASTERIDE, LISINOPRIL, OLANZAPINE, FELODIPINE, APAP. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Oct 12, 2006. Male patient, 57 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, pneumonia. ETODOLAC dosage: unknown. Patient died.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on Nov 01, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: adhesion, candidiasis, condition aggravated, gastric ulcer perforation, gastrointestinal fistula, muscular weakness, pleural effusion, pleural fistula, pneumothorax. ETODOLAC dosage: 400 MG 1X PER 1 DAY ORAL; ^ LONG TIME ^. During the same period patient was treated with PREDNISONE, METHOTREXATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2006. Female patient, 47 years of age, was diagnosed with arthralgia and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice, lymphocyte stimulation test positive, pruritus. ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on Nov 14, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal adhesions, abscess, aspiration pleural cavity abnormal, back pain, candidiasis, chest pain, condition aggravated, culture positive. ETODOLAC dosage: 400 MG 1X PER 1 DAY, ORAL. During the same period patient was treated with PREDNISONE, RHEUMATREX, FAMOTIDINE. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2006. Male patient, 63 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: asthenia, asthma, dizziness, emphysema, hypotension, pallor, respiratory arrest. ETODOLAC dosage: 300 MG 3X PER 1 DAY, ORAL. During the same period patient was treated with VASOTEC, ELDEPRYL, SINEMET, PREDNISONE, NITROSTAT, METHOTREXATE, TRAZODONE. Patient died on 09/13/2000.
Health Professional from JAPAN reported ETODOLAC problem on Nov 17, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: candidiasis, condition aggravated, culture positive, gastric ulcer perforation, gastrointestinal fistula, mediastinal disorder, muscular weakness, peritoneal adhesions, pleural effusion. ETODOLAC dosage: 400 MG 1X PER 1 DAY. During the same period patient was treated with FAMOTIDINE, PREDNISONE, RHEUMATREX. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, chest discomfort, chest pain, dyspnoea, gastric ulcer perforation, gastrointestinal fistula, inflammation, pleural effusion, pneumothorax. ETODOLAC dosage: 400 MG; QD. During the same period patient was treated with PREDNISOLONE, PREDNISOLONE PHOSPHATE, METHOTREXATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ETODOLAC problem on Dec 12, 2006. Male patient, 79 years of age, weighting 176.0 lb, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. ETODOLAC dosage: 300 MG TID. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Nov 28, 2006. Female patient, 72 years of age, was diagnosed with spinal osteoarthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: haematuria, pharyngolaryngeal pain, skin test positive, stevens-johnson syndrome, toxic epidermal necrolysis. ETODOLAC dosage: 400 MG 1X PER 1 DAY, ORAL. During the same period patient was treated with LEVOTHYROXINE, ALFEROL, OLMETEC, SELBEX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ETODOLAC problem on Dec 18, 2006. Female patient, 54 years of age, weighting 204.0 lb, was diagnosed with knee operation and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blister, burning sensation, erythema, pruritus, urticaria. ETODOLAC dosage: unknown. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Dec 11, 2006. Male patient, 46 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anaemia, blood lactate dehydrogenase increased, dyspepsia, face oedema, renal failure acute. ETODOLAC dosage: 300 MG 1X PER 1 DAY ORAL. During the same period patient was treated with AURANOFIN, BUCILLAMINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported ETODOLAC problem on Dec 11, 2006. Female patient, 76 years of age, was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: dermatitis allergic. ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on Dec 12, 2006. Male patient, 33 years of age, was diagnosed with back pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, dyspnoea. ETODOLAC dosage: 400 MG 1X PER 1 DATY. During the same period patient was treated with RINLAXER, ISALON, AZULENE, MOHRUS. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported ETODOLAC problem on July 09, 2007. Female patient, 73 years of age, was diagnosed with rheumatoid arthritis, hypertonic bladder, hypertension and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: fall, oedema peripheral, thrombosis. ETODOLAC dosage: unknown. During the same period patient was treated with OXYTROL, DILTIAZEM. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from JAPAN on July 09, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, glomerulonephritis membranous, oedema peripheral, proteinuria. ETODOLAC dosage: 400MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported ETODOLAC problem on July 23, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, musculoskeletal stiffness. ETODOLAC dosage: unknown. Patient was hospitalized. Patient recovered.
ETODOLAC problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Male patient, 60 years of age, weighting 346.0 lb, was diagnosed with osteoarthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: gastric haemorrhage. ETODOLAC dosage: 400MG TID PO. Patient was hospitalized. Patient recovered.
Physician from INDIA reported ETODOLAC problem on Aug 21, 2007. Male patient, 53 years of age, weighting 121.3 lb, was diagnosed with cachexia and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, dyspnoea, haemoptysis, heart rate increased, respiratory rate increased, vertigo. ETODOLAC dosage: unknown. During the same period patient was treated with PROPRANOLOL, ZOLEDRONIC ACID, NEUROBION, FAMOTIDINE. Patient died on 07/14/2007.
ETODOLAC problem was reported by a Pharmacist from UNITED STATES on Sept 13, 2007. Male patient, 89 years of age, was diagnosed with osteoarthritis and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: diverticulum, gastric ulcer, gastrointestinal pain, haemoglobin decreased, hiatus hernia, melaena, oesophagitis, procedural complication. ETODOLAC dosage: 300MG BID PO. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported ETODOLAC problem on Sept 24, 2007. Male patient, 66 years of age, was diagnosed with pain and was treated with ETODOLAC. After drug was administered, patient experienced the following problems/side effects: leukopenia. ETODOLAC dosage: 400MG BID PO. Patient was hospitalized. Patient recovered.